Back to OfferingsMARIN’s Pathways Research provides a deep dive into the evolving role of clinical pathways in oncology, examining how they shape treatment decisions, drug utilization, and market access strategies. As payers, IDNs, and community practices refine their pathway models, understanding these frameworks is essential for optimizing engagement and ensuring product access.
Our research delivers comprehensive insights into pathway adoption, enforcement mechanisms, and the influence of key stakeholders. The 2024 Pathways Report explores how pathways impact prescribing behavior, the role of financial incentives, and emerging trends in pathway development—giving you the intelligence needed to align strategies with decision-makers and adapt to the changing oncology treatment landscape.
